Showing results (351-360 of 462) with videos related to
Sort By:
Pageof 47
Pharmacogenomics|July 1, 2015
Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestryAna Alfirevic, Jill Durocher, Anisa Elati, et al.Communications Medicine|October 8, 2024
Disease coverage of human genome-wide association studies and pharmaceutical research and developmentMaría Gordillo-Marañón, Amand F Schmidt, Alasdair Warwick, et al.Epilepsia|July 17, 2016
An integrative in silico system for predicting dysregulated genes in the human epileptic focus: Application to SLC transportersNasir Mirza, Olga Vasieva, Richard Appleton, et al.Transplantation|January 12, 2010
Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathyAlieu B Amara, Asheesh Sharma, John L Alexander, et al.The Lancet. Gastroenterology & Hepatology|November 18, 2017
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studiesJames W Dear, Joanna I Clarke, Ben Francis, et al.Blood|December 11, 2012
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemiaAthina Giannoudis, Lihui Wang, Andrea L Jorgensen, et al.BMC Medicine|November 16, 2013
Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospitalJennifer R Bellis, Jamie J Kirkham, Signe Thiesen, et al.Clinical Pharmacology and Therapeutics|February 3, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 UpdateElizabeth J Phillips, Chonlaphat Sukasem, Michelle Whirl-Carrillo, et al.BMJ Open|August 28, 2020
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II)Silviya Balabanova, Claire Taylor, Graeme Sills, et al.The Lancet. Global Health|September 20, 2025
Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trialRonald Kiguba, Helen B Ndagije, Norah Mwebaza, et al.Pageof 47